Major Drivers Propelling the Growth oh theEnzyme-Linked Immunosorbent Assay Testing Market Forward: Rising Incidence Of Infectious Disorders Driving Growth In ELISA Testing Market
Discover trends, market shifts, and competitive outlooks for the enzyme-linked immunosorbent assay testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has The Enzyme-Linked Immunosorbent Assay Testing Market Growth Evolved From 2024 To 2025, And What’s Ahead?
In recent times, the market size of the enzyme-linked immunosorbent assay testing has witnessed substantial growth. It is projected to expand from $2.85 billion in 2024 to about $3.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.7%. The considerable growth during the historic period can be associated with factors such as the prevalence of chronic illnesses, rising allocations and focus on biomedical investigations, authorization of ELISA examinations by regulatory entities, government-led initiatives, and programs aimed at promoting health awareness.
In the coming years, the enzyme-linked immunosorbent assay testing market is projected to experience robust growth. It is estimated that it will reach a value of $3.88 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this anticipated growth during the forecast period include increased interest in personalized medicine, an expanding elderly population, heightened focus on early identification, better access to healthcare services, and an emerging need for the surveillance of chronic diseases. Key trends expected during this forecast period are technological progress, a rising call for point-of-care testing, broader application landscapes, the integration of high-throughput screening, and the development of digital ELISA.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19417&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Enzyme-Linked Immunosorbent Assay Testing Market?
The rise in infectious diseases is anticipated to fuel the expansion of the enzyme-linked immunosorbent assay testing market. These disorders are a result of pathogenic organisms like bacteria, viruses, fungi or parasites, which can be transferred among individuals and can affect multiple bodily systems. The surge in infectious diseases can be attributed to the increased global travel and increasing antimicrobial resistance, making infection control complicated. The enzyme-linked immunosorbent assay (ELISA) testing plays a critical role in diagnosing such disorders as it allows the precise identification and measure of specific antigens or antibodies related to the infection, assisting in diagnosis, tracking disease progression, and assessing the effectiveness of the treatment. In February 2024, the World Health Organization, a Switzerland-based intergovernmental public health organization, reported 58114 measles cases (a highly infectious viral disease) in the European Region in 2023, a stark increase from 941 in 2022. Hence, the rise in infectious diseases is contributing to the upward trend in the enzyme-linked immunosorbent assay testing market.
Which Key Market Segments Comprise the Enzyme-Linked Immunosorbent Assay Testing Market and Drive Its Revenue Growth?
The enzyme-linked immunosorbent assay testingmarket covered in this report is segmented –
1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users
Subsegments:
1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA
2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA
3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19417&type=smp
Which Areas Are Leading Regions in the Enzyme-Linked Immunosorbent Assay Testing Market Expansion Across the Globe?
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2024. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Enzyme-Linked Immunosorbent Assay Testing Market?
Key players in the enzyme-linked immunosorbent assay testing market are expanding their products by introducing novel innovations such as advanced enzyme-linked immunosorbent assay (ELISA) kits to improve diagnostic precision and cater to diverse research and clinical requirements. These novel ELISA kits represent the next generation of ELISA tests providing enhanced accuracy, heightened sensitivity, and user-friendly features for the identification and quantification of biomarkers. For example, Charles River Laboratories, a pharmaceutical company based in the US, launched an innovative enzyme-linked immunosorbent assay (ELISA) kit in February 2023. It aids in the detection and measurement of residual host cell proteins (HCP) present in CHO-based biotherapeutics. The groundbreaking kit employs avian immunoglobulin Y (IgY) antibodies obtained from specific pathogen-free (SPF) chicken eggs, resulting in exceptional sensitivity and specificity with detection thresholds as low as 0.1 ng/mL and 90% antibody coverage. The purpose of this introduction is to enhance quality control in biopharmaceutical development, ensuring the safety and effectiveness of new therapies and also providing flexibility for usage by customers, either independently or with assistance from Charles River’s expert team.
View the full report here:
How Is the Enzyme-Linked Immunosorbent Assay Testing Market Conceptually Defined?
Enzyme-linked immunosorbent assay (ELISA) testing refers to a widely used laboratory technique designed to detect and quantify specific proteins, antigens, or antibodies in a sample. This method involves immobilizing an antigen or antibody on a solid surface, typically a microplate, and then using enzyme-linked antibodies or antigens to bind to the target molecule.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19417
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
